Testing effectiveness (Phase 2)WithdrawnNCT05209308What this trial is testingRituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLLWho this might be right forCLL MEI Pharma, Inc.
Early research (Phase 1)Study completedNCT00098891What this trial is testingMS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or LymphomasWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+41 more National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT00720785What this trial is testingNatural Killer Cells and Bortezomib to Treat CancerWho this might be right forChronic Myeloid Leukemia (CML)Pancreatic CaColon/Rectal Ca+2 more National Heart, Lung, and Blood Institute (NHLBI) 35
Testing effectiveness (Phase 2)Looking for participantsNCT05031897What this trial is testingTwo Step Haplo With Radiation ConditioningWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAdult T-Cell Leukemia/Lymphoma+14 more Thomas Jefferson University 63
Early research (Phase 1)Study completedNCT00005639What this trial is testingAzacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous TreatmentWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Large-scale testing (Phase 3)Study completedNCT03730129What this trial is testingHumoral Immunodeficiency in CLL and Therapy With Subcutaneous IgWho this might be right forSecondary Immune Deficiency Disorder Rochester General Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00337246What this trial is testingCombination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaWho this might be right forLeukemia Cancer Research UK 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT05069051What this trial is testingBelimumab in Patients with Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphoid Leukemia in Relapse University Hospital Tuebingen 120
Testing effectiveness (Phase 2)Looking for participantsNCT06978088What this trial is testingLP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of ThisWho this might be right forChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaSmall Lymphocytic LymphomaCLL/SLL+1 more Zulfa Omer 34
Testing effectiveness (Phase 2)Study completedNCT00005829What this trial is testingGemcitabine in Treating Patients With Recurrent Chronic Lymphocytic LeukemiaWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 22
Testing effectiveness (Phase 2)Study completedNCT00143845What this trial is testingStudy of Low-Intensity Conditioning for Allogeneic Stem Cell TransplantWho this might be right forMultiple MyelomaLymphocytic Leukemia, ChronicLymphoma, Low-Grade University of Michigan Rogel Cancer Center 54
Large-scale testing (Phase 3)Study completedNCT00265837What this trial is testingLaboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Not applicableLooking for participantsNCT07487428What this trial is testingCLL-IMPACT: A Clinical Nutrition Trial Investigating Immune and Metabolic Changes in Early-Stage CLLWho this might be right forCLL (Chronic Lymphocytic Leukemia) Technical University of Munich 50
Testing effectiveness (Phase 2)Looking for participantsNCT04771507What this trial is testingA Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Jeanette Lundin 50
Not applicableEnded earlyNCT00952185What this trial is testingInfluenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more City of Hope Medical Center 9
Not applicableStudy completedNCT00547196What this trial is testingAlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & DisordersWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes City of Hope Medical Center 10
Early research (Phase 1)Study completedNCT00002980What this trial is testingDecitabine in Treating Patients With Melanoma or Other Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more California Cancer Consortium
Early research (Phase 1)Study completedNCT00623870What this trial is testingRO5045337 [RG7112] in Patients With Hematologic Neoplasms.Who this might be right forHematologic Neoplasms Hoffmann-La Roche 116
Testing effectiveness (Phase 2)Study completedNCT00073489What this trial is testingA Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Astellas Pharma Inc 23